BioSig Technologies, Inc.
BSGM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $1 | $0 | $0 |
| Gross Profit | $0 | -$1 | -$0 | $0 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $20 | $3 | $1 |
| SG&A Expenses | $5 | $20 | $3 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Expenses | $6 | $20 | $3 | $1 |
| Operating Income | -$6 | -$20 | -$3 | -$1 |
| % Margin | – | – | – | -9,100% |
| Other Income/Exp. Net | -$10 | -$0 | $0 | $0 |
| Pre-Tax Income | -$16 | -$20 | -$3 | -$1 |
| Tax Expense | -$1 | $0 | $0 | $0 |
| Net Income | -$16 | -$20 | -$3 | -$1 |
| % Margin | – | – | – | -8,453.8% |
| EPS | -0.47 | -0.74 | -0.02 | -0.008 |
| % Growth | 36.5% | -3,600% | -156.4% | – |
| EPS Diluted | -0.47 | -0.74 | -0.02 | -0.008 |
| Weighted Avg Shares Out | 334 | 277 | 140 | 140 |
| Weighted Avg Shares Out Dil | 334 | 277 | 140 | 140 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$15 | -$20 | -$3 | -$2 |
| % Margin | – | – | – | -17,776.9% |